ALFA Finder| Management target | Revenue 16.0% FY27 |
|---|
| Revenue growth | 19% GWP growth; insurance revenue growth targeting 15-16%. |
|---|---|
| Margins | CISR improved to 97%; Underwriting profit rose to Rs. 111 crore. |
| Demand visibility | Strong; fresh business growth from non-metro geographies up 3.5x metros. |
| Management confidence | High; citing multi-decadal growth opportunity in retail health insurance. |
Growth
GWP grew 19% YoY to Rs. 4,672 crore; PAT rose 25% to Rs. 550 crore.
Outlook
Targeting mid-to-high teen ROE; insurance revenue growth guided to converge toward 15-16% during the year.
Risks
Seasonal infectious disease outbreaks in Q2; potential volatility in investment income mark-to-market impacts.
Last quarter's promises, checked
Delivered
- Guided 1 lakh agents/year → delivered 20,000 in Q1 (= BEAT on run-rate)
- Guided sustainable high-teen growth → delivered 19% GWP growth (= BEAT)
- Guided mid-to-high teen ROE → delivered 13.1% normalized ROE (= BEAT on trajectory)
Partly delivered
- Guided 15% NEP growth range → delivered 15-16% insurance revenue target (= PARTIAL)
Investor Presentation filed with BSE, NSE: STARHEALTH. Summary written with AI assistance from the document.
Star Health and Allied Insurance Company Ltd: key numbers
- Share price
- ₹557.80
- Market cap
- ₹32,781 Cr
- Revenue (annual)
- ₹17,825 Cr
- Net profit (annual)
- ₹557.0 Cr
- P/E (TTM)
- 31.1×Sector 20.8×
- Promoter holding
- 58.00%-0.01% QoQ
- FII holding
- 15.86%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Star Health and Allied Insurance Company Ltd
All →Star Health and Allied Insurance Company Capital Structure Change
Star Health received IRDAI approval for HDFC Mutual Fund schemes to acquire equity up to 9.99% of paid-up capital, up from 4.49%. The approval extends the fund's existing stake and does not involve a stated rupee amount.
Star Health and Allied Insurance Company Results Update
Star Health reported Normalised PAT of ₹390 Crores in Q2 FY27, up 70% YoY. H1 FY27 PAT stood at ₹815 Crores, up 57% YoY.
Star Health and Allied Insurance Company Earnings Call Transcript: Key Takeaways
Star Health reported a significant structural turnaround with underwriting profitability for the fifth consecutive quarter.
- Call
- Guides 20% growth
Star Health and Allied Insurance Company Other Announcement
Star Health filed a NIL Reg 54 security cover certificate for unsecured NCDs. No secured debt is covered, so this is routine compliance.
Star Health and Allied Insurance Company Investor Presentation: Key Takeaways
H1 FY27 PAT ₹815 Cr (+57%); CISR improved to 97.9% from 100.3%; underwriting result ₹210 Cr vs loss ₹24 Cr. Retail fresh GWP +36%, driven by agency and D2C. Reported profit includes ₹229 Cr MTM gain.
Star Health and Allied Insurance Company Promoter Reclassification
Star Health's board approved reclassifying Sthitaprajna Advisors LLP from promoter group to public shareholder category. The move is subject to requisite regulatory approvals.